Phenylethanolamine N-methyltransferase (PNMT) gene and early-onset Alzheimer disease

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 105, Issue 4, 2001, Pages 312-316

  Mann, Michael B ^a,b   Wu, Shijuan ^a   Rostamkhani, Massud ^a   Tourtellotte, Wallace ^c   MacMurray, James ^d   Comings, David E ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b CALIFORNIA STATE POLYTECHNIC UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d MGI Applied Genomics ^*  (United States)

Author keywords

Alzheimer disease; Epinephrine; Norepinephrine; PNMT

Indexed keywords

PHENYLETHANOLAMINE N METHYLTRANSFERASE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; ENZYME ACTIVITY; GENE ISOLATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC CODE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NERVE DEGENERATION; PRIORITY JOURNAL; PROMOTER REGION;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; DNA; GENE FREQUENCY; GENOTYPE; HUMANS; MIDDLE AGED; PHENYLETHANOLAMINE N-METHYLTRANSFERASE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

EID: 0035826537     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.1363     Document Type: Article

References (27)

1. Catecholaminergic neurons in the ventrolateral medulla and nucleus of the solitary tract in the human
2. Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease
3. Choline acetyltransferase mRNA expression in the striatal neurons of patients with Alzheimer's disease
4. Evidence for retrograde degeneration of epinephrine neurons in Alzheimer's disease
5. Phenylethanolamine N-methyltransferase activity is decreased in Alzheimer's disease brains
6. Evidence for decreased transport of PNMT protein in advanced Alzheimer's disease
7. Degenerative changes in epinephrine tonic vasomotor neurons in Alzheimer's disease
8. Molecular heterosis: A review
9. Selective loss of central cholinergic neurons in Alzheimer's disease
10. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa
11. Cholinergic innervation of the amygdaloid complex in the human brain and its alterations in old age and Alzheimer's disease
12. A single transmitter regulates gene expression through two separate mechanisms: Cholinergic regulation of phenylethanolamine N-methyltransferase mRNA via nicotinic and muscarinic pathways
13. Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism
14. A full genome scan for late onset Alzheimer's disease
15. Excitatory amino acid-releasing and cholinergic neurones in Alzheimer's disease
16. Strain differences in distribution of phenylethanolamine N-methyltransferase activity from rat brain and adrenal gland
17. Neuropathological and biochemical observations on the noradrenergic system in Alzheimer's disease
18. Strain differences in rat brain epinephrine synthesis: Regulation of alpha-adrenergic receptor number by epinephrine
19. Alzheimer's disease: Genetic studies and transgenic models
20. Confirmation of the genetic association of interleukin-1A with early onset sporadic Alzheimer's disease
21. Cholinergic deficit in Alzheimer's disease: A study based on CSF and autopsy data
22. Molecular forms of acetylcholinesterase in subcortical areas of normal and Alzheimer disease brain
23. Dementia of the Alzheimer's type
24. Senile dementia of the Alzheimer's type
25. Two single polymorphisms in the promoter region of the human phenylethanolamine N-methyltransferase PNMT gene
26. Nucleus raphe dorsalis in Alzheimer's disease: Neurofibrillary tangles and loss of large neurons